BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE and EMOTIONAL DISTRESS

2,425 reports of this reaction

3.9% of all BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE reports

#11 most reported adverse reaction

Overview

EMOTIONAL DISTRESS is the #11 most commonly reported adverse reaction for BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, manufactured by Gilead Sciences, Inc.. There are 2,425 FDA adverse event reports linking BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE to EMOTIONAL DISTRESS. This represents approximately 3.9% of all 62,897 adverse event reports for this drug.

Patients taking BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE who experience emotional distress should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

EMOTIONAL DISTRESS2,425 of 62,897 reports

EMOTIONAL DISTRESS is moderately reported among BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE

In addition to emotional distress, the following adverse reactions have been reported for BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE:

Other Drugs Associated with EMOTIONAL DISTRESS

The following drugs have also been linked to emotional distress in FDA adverse event reports:

ABACAVIR SULFATEADENOSINEATAZANAVIRBUPRENORPHINEBUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDECOBICISTATCOMFREY ROOTCOPPERDARUNAVIRDIETHYLPROPION HYDROCHLORIDEDOCETAXELDOCETAXEL ANHYDROUSDOLUTEGRAVIR SODIUMDROSPIRENONE AND ETHINYL ESTRADIOLELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDEELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATEEMTRICITABINEEMTRICITABINE AND TENOFOVIR ALAFENAMIDEEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEETOMIDATE

Frequently Asked Questions

Does BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE cause EMOTIONAL DISTRESS?

EMOTIONAL DISTRESS has been reported as an adverse event in 2,425 FDA reports for BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is EMOTIONAL DISTRESS with BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE?

EMOTIONAL DISTRESS accounts for approximately 3.9% of all adverse event reports for BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, making it a notable side effect.

What should I do if I experience EMOTIONAL DISTRESS while taking BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE?

If you experience emotional distress while taking BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE Full ProfileAll Drugs Causing EMOTIONAL DISTRESSGilead Sciences, Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.